NASDAQConsumer DiscretionaryElectrical Equipment & PartsSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|---|---|
| Quarter ending 2026-12-30 | ||
| Revenue | — | 3.4M |
| EPS | — | -95,040 |
Management figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Successfully execute M&A and partnerships to expand business | It is pursuing acquisitions to expand its business. | Improving | Failure to complete any meaningful M&A or partnership in next 4 quarters | Qualitative: 2 M&A/partnership events (Sep-Oct 2026) vs target >=1 NVVE entered two material definitive agreements (Securities Purchase Agreements) in Sep and Oct 2026. Context reviewed through Oct 19, 2026Last status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 3 of last 3 quarters. Management disclosed multiple material definitive agreements including acquisitions and convertible note issuances in 2026. The activity shows ongoing pursuit of M&A and partnerships, indicating delivering on this strategic priority. Delivery assessment Oct 24, 2026 |
Grow revenue to support financial improvement | A primary condition in NUVVE HOLDING CORP's published investment case. The stated target is Revenue grows at least 10% YoY next 4 quarters. | Intact | Revenue growth falls below 10% YoY next 4 quarters | Revenue: $1.227M FY2026-Q2; GAAP. Published target: Revenue grows at least 10% YoY next 4 quarters. Target and observation units differ. Source published Aug 14, 20261,226,726 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 0323feb0-32e3-4207-a12e-2fdfc8f9ee33. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Manage capital and equity financing to support liquidity | A supporting condition in NUVVE HOLDING CORP's published investment case. The stated target is Maintain stable capital structure and avoid new large debt over next year. | Under Pressure | New large debt or equity dilution that worsens financial risk | New debt $280k + equity dilution vs stable capital structure target Company issued $280k convertible note and sold unregistered equity, confirming new debt and dilution. Context reviewed through Oct 19, 2026Last status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 3 of last 3 quarters. The company raised $2.5 million in Q2 2026 and issued a $280,000 convertible promissory note in Q3 2026, alongside a $1.5 million term loan agreement. These actions demonstrate active capital allocation and financing management, delivering on stated priorities. Delivery assessment Oct 24, 2026 |
Reduce operating losses toward financial stability | The company aims to reduce operating losses, which were about -$6.7M in 2025-Q4. | Broken | Operating losses remain worse than -$5M over next 4 quarters | Operating income: $-7.448M FY2026-Q2; GAAP. Published target: Operating loss improves to better than -$5M next 4 quarters. Target period is not explicitly aligned with this observation. Source published Aug 14, 2026-7,448,120 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 0323feb0-32e3-4207-a12e-2fdfc8f9ee33. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative growth and turnaround case, not a proven durable compounder. The multi-year thesis is on watch: revenue and operating losses have improved, but recent performance remains weak and management execution is mixed.
The valuation model suggests NVVE is cheap versus peers, but confidence in that comparison is low. Its expectations gap is strongly negative, while the priced-in assessment is tagged justified, so the evidence does not point to a clear mismatch between expectations and the business outlook.
Near term, earnings risk is elevated after consecutive misses, and the evidence flags a high chance of another miss. Over the multi-year view, revenue growth and lower operating costs are constructive, but gross margin fell sharply and losses remain; recent agreements and financing activity also bring added obligations.
The main company-level test is whether revenue growth can translate into healthier gross margins and continued reductions in cash operating losses. The near-term sector backdrop also matters: stronger or weaker results from sector bellwethers could shape momentum, while a material slowdown in GDP growth could weigh more heavily on growth-sensitive companies like NVVE.
For the next 1 to 3 years, NVVE is a fragile, loss-making growth case with signs of progress on revenue and costs, but profitability and execution remain unproven. The long-term thesis hinges on better margins, sustained cost control, and disciplined follow-through on strategic deals. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.